Clinical trial
Early Pharmacotherapy Aimed at Neuroplasticity in Autism: Safety and Efficacy
NCT00166621 · Chugani, Diane C., Other · Completed
Key facts
| NCT number | NCT00166621 |
|---|---|
| Title | Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy |
| Official title | Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy |
| Lead sponsor | Chugani, Diane C., Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Buspirone |
| Enrollment | 20 |
| Start date | Mar 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: